SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 21.99% in the revenue at Rs. 3550.00 millions was reported in the March 2024 quarter as compared to Rs. 2910.00 millions during year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -1260.00 millions as compared to Net Loss of Rs. -2990.00 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 improved to -220.00% as compared to -10.00% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3550.00 2910.00 21.99 11540.00 10720.00 7.65 11540.00 10720.00 7.65
Other Income 240.00 290.00 -17.24 410.00 670.00 -38.81 410.00 670.00 -38.81
PBIDT -220.00 -10.00 2100.00 50.00 1370.00 -96.35 50.00 1370.00 -96.35
Interest 590.00 580.00 1.72 2370.00 2290.00 3.49 2370.00 2290.00 3.49
PBDT -810.00 -2440.00 -66.80 -2460.00 -3270.00 -24.77 -2460.00 -3270.00 -24.77
Depreciation 450.00 450.00 0.00 1760.00 1860.00 -5.38 1760.00 1860.00 -5.38
PBT -1260.00 -2890.00 -56.40 -4220.00 -5130.00 -17.74 -4220.00 -5130.00 -17.74
TAX 0.00 100.00 0.00 0.00 -470.00 0.00 0.00 -470.00 0.00
Deferred Tax 0.00 100.00 0.00 0.00 -470.00 0.00 0.00 -470.00 0.00
PAT -1260.00 -2990.00 -57.86 -4220.00 -4660.00 -9.44 -4220.00 -4660.00 -9.44
Equity 770.00 720.00 6.94 770.00 720.00 6.94 770.00 720.00 6.94
PBIDTM(%) -6.20 -0.34 1703.61 0.43 12.78 -96.61 0.43 12.78 -96.61

Wockhardt Share Price

1396.80 37.70 (2.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×